Tucatinib Regimen Boosts PFS in Advanced HER2-Positive Breast Cancer
SAN ANTONIO -- Adding tucatinib (Tukysa) to trastuzumab emtansine (T-DM1; Kadcyla) reduced the risk of disease progression or death by ...
Read moreDetailsSAN ANTONIO -- Adding tucatinib (Tukysa) to trastuzumab emtansine (T-DM1; Kadcyla) reduced the risk of disease progression or death by ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info